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Estimation and Inference in Metabolomics with Nonignorable Missing Data
Shangshu Zhao, M.S.
University of Pittsburgh, 2021
Mass-Spectrometry(MS) is one of the most important methods used to characterize
metabolomics data. However large-scale MS metabolomics data always faces the problem
of data points unobserved or lost, whose magnitude could reach a level where it can’t be
simply ignored. To account for the information hidden within missing values, we developed
a methods to analyze metabolomics data with missing data based on MetabMiss, a newly
developed rigorous method to model missing values. Our methodology shows an overall
better performance on estimating both coefficients and variance and other criteria, which
gives us advantages doing further statistical inference. For each criteria, we demonstrate our
method on a simulation data set to compare it to other classical methods.
Keywords metabolomics, missing not at random (MNAR), PCA, WGCNA.
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1.0 Introduction
With the development of biology characteristic technology, metabolomics data are be-
coming more and more easy to access, which gives researchers more opportunities to analyze
bio-activities on metabolites level. However, large-scale metabolomics data always faces
several problem that makes it not easy to be directly analyzed.
The main problem is that there will always exist a large amount of missing values in the
data set, of which a considerable portion are missing at 50% or even more. Thus, simply
ignoring the missing values will significantly reduce the total information we are able to
utilize from the data set. On the other hand, missing value themselves could be considered
as a kind of information that maybe related to underlying true data. From this intuition
combined with our understanding to experimental equipment, imputation is developed to fill
in the missing value by varies ways, from which we are able to analyze the data. However,
imputation methods highly depend on the structure of true metabolomics data, which leaves
a paradox that we cannot decide the data structure before analysis.
To get a more robust solution for this problem, MetabMiss [4] propose a novel method
that basically assumes missing probabilities are from a certain distribution which is related to
the underlying true value of metabolomics concentration, as well as other control parameters.
This gives them a way more robust and efficient way to evaluate the missing probabilities.
Based on their work, we took a closer look at metabolomics data, and found that there are
more structure information that we are able to harvest from. We then developed a novel




Estimating coefficients of interest has always been difficult since the existence of missing
value. Thanks to MetabMiss from [4], we are able to get an efficient and useful modeling
method. Based on MetabMiss and a bit more assumptions on the In this chapter, I’ll
introduce how we model the MS metabolomics data with missing values.
2.1 Notation
We use 1n,0n ∈ Rn to denote all ones and all zeros vector, In ∈ Rn to denote identity
matrix, with n > 0 a integer, [n] the set {1, . . . , n}. In terms of the vector and matrix,
xi denotes the i
th element of vector x ∈ Rn, and Mij denote the (i, j)th element of matrix
M ∈ Rn×m. N (·;µ, τ) is the likelihood function for normal distribution with mean µ and
variance τ .
2.2 A Description of Data Generating Model
We let ygi denote the observed or unobserved log-transformed metabolite integrated
intensity for metabolite g ∈ [p] in sample i ∈ [n], which is proportional to a metabolite’s
concentration in sample. Let X = (x1, . . . , xn)
> ∈ Rn×d and C = (c1, . . . , cn)> ∈ Rn×K
be observed and unobserved covariates (i.e. latent factors), where the former may contain
biological factors like personal disease history, and technical factors that may be related to
experiment condition. Therefore the mean model for ygi is given by:
ygi = x
>
i βg + c
>
i `g + εgi, εgi ∼ N (0, σ2g), g ∈ [p]; i ∈ [n]. (1)
For the residuals term, we assume that the {egi}g∈[p],i∈[n] are independent and {egi}i∈[n] are
identically distributed for each g ∈ [p]. Compared to the model in [4], which assumed a more
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general model for the residuals, here we assume the residuals to be normally distribution.
This assumption could be justified by general metabolomics data as we plot below:
Figure 1: Normal QQ-plot of the Fully Observed Metabolites in Copsac Data
For latent factors, we assume the that c1, . . . , cn are independent and are independent 
of {egi}g∈[p],i∈[n]. But for the overall sample data, We do not assume an specific probability 
form for ygi, due to our current ignorance of the missing mechanism.
We next introduce the missing mechanism model. Let ri be an indicator for whether or 
not yi is observed, (ri = 1 if yi is observed and ri = 0 otherwise). Missing mechanism is then
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modeled as below where Ψ() denotes for cumulative distribution function for t-distribution.
P (rgi = 1 | ygi) = Ψ {αg (ygi − δg)} , g ∈ [p]; i ∈ [n] (2)
As you may see in the above equation, there are two metabolites-dependent parameters. αg
and δg ∈ R are scale and location parameter, respectively. They behave in a way that αg ↘ 0
implies that the metabolites are missing completely at random (MCAR), and αg ↗∞ implies
ygi is left censored at δg. Scale parameter δg, respectively.
2 is a classic model for missing data in untargeted mass spectrometry experiments[1].
Typical choices for Φ include the logistic function, an exponential probabilistic model. Here,
we inherited Φ(x) = F4(x) from our previous work([4]), which we believe is a more robust
option. This has previously been used as a robust alternative to logistic and probit functions.
We assume (y1, r1), ..., (yn, rn) are independent and identical to each other. Conditional
on Y = {ygi}g∈[p],i∈[n] ∈ Rp×n, {rgi}g∈[p],i∈[n] is independent.
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3.0 Estimation and Inference of Coefficients of Phenotype
In this chapter, I will introduce how to get better estimates for the coefficients when there
are data missing not at random(MNAR). Then I will give an estimation of the coefficients
variance. In the end, I will compare our method to other existing widely-used methods, like
imputation. It will be showed that compared to classic imputation, our method gives an
overall more precise and robust estimations.
3.1 Efficient Estimation by MLE
Maximum likelihood estimation(MLE) is one of the most widely used method in modern
statistics to estimate the parameters of a probability distribution. By maximizing a likelihood
function over feasible parameter space, the observed data is most probable under the assumed
statistical model.
Considering that estimating latent factors is not the focus of this thesis, I will treat the
latent factors C as known terms in the rest of this thesis. In this case, I could develop
a better estimate of coefficients for both observed and latent factors based on our original
estimates. For simplicity, I will rewrite the mean model for the remainder of this chapter as:
ygi = z
T
i ηg + egi, egi ∼ (0, σ2g), g ∈ [p]; i ∈ [n] (3)
where zi represents observed and latent factors, which are assumed to be fully observed here.
Based on our normal assumption and the missing mechanism model, we can write the
log-likelihood function for this model, up to constants that do not depend on η, σ, α and δ,
5
is:






N (yi; zTi η, σ2)P (ri = 1 | yi)
}ri














(1− ri) log P(ri = 0 | zi)
(4)
where P (ri = 1 | yi) = Ψ{α(yi − δ)} depends on α and δ, while P (ri = 0 | zi) depends on
η, σ, α and δ,
P(ri = 0 | zi) = 1−P(ri = 1 | zi) = 1−
∫





α(zTi η + σε− δ)
}
φ(ε)dε
Let f(x) = dΨ(x)
dx
and ḟ(x) = df(x)
dx
, and φ(x) be the pdf for the standard normal distri-



















α(zTi η + σε− δ)
}
φ(ε)dε.
Since this thesis is not focused on inference about missing mechanism, I assume for
simplicity that α,δ,zi and σ
2 are known. Detailed derivation about the parameters could be
found at [4]. Thus up to constants that do not depend on η, we can write the log-likelihood,
score function and Hessian as




ri(yi − zTi η)2 +
n∑
i=1
(1− ri) log {1− g1,i(η)} ∈ R (5a)













zi ∈ Rd (5b)




















Then we can get our estimation by numerically optimizing the likelihood function for metabo-
lites with missing proportion between 5% to 50%. As I’ve said above, this thesis aims to
develop an efficient and easy-to-use software for the furture metabolomics research. Our al-
gorithm are designed to be both accurate and computing-efficient. There are multiple ways
to do numerical optimization in high dimension, in which we found BFGS algorithm is the
most suitable method for us. Given a fair starting value from the MetabMiss software, we
managed to keep the run-time for one simulation in under 5 seconds.
3.2 Finite Sample-Corrected Variance of Coefficients Estimations
In this section, I’ll introduce how we get a good estimate for the variance of coefficients es-
timator with sample correction. To get variance of coefficients estimations, which is denoted
as V(η̂), we first have, by Taylor’s Theorem,
η̂ − η = L (η̃) s (η) ,
where η̃ lies on the line adjoining η and η̂ and L (η̃) = {−H (η̃)}−1. Compare to s (η),
where the uncertainty mainly from, we temporarily ignore the uncertainty in L = L (η̃),
and treat it as a known constant, then we can write
V (η̂) = V {L (η̃) s (η)} = L(η̂)V {s (η)}L(η̂).
However, when the dimension of coefficients increases, the estimation of variance will be
significantly deflated. This phenomenon widely exists when estimating high dimensional
coefficients due to the large degrees of freedom they brings into the system. In OLS, we have
a mutual inflation factor to solve this problem by multiplying the estimation to a factor in
the form of 1
n−p . But when there exist missing values, we need to develop a new way to do
this. To get a finite-sample corrected estimate for V (η̂) that corrects the observed variance
deflation, a better estimate for V {s (η)} is rather crucial using the data we have available.
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To start, note that











si (η) si (η)
T ,
where when dimension of coefficients increases, E
{
si (η) si (η)
T
}
become more and more
close to zero. Thus we approximate E
{
si (η) si (η)
T
}
with the third term in the above
equation to extend the variance inflation factor developed in [4] to these data. As we defined
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Considering the two different situations(observed and unobserved), we split estimating score
functions si(η) into two parts(detailed prove and explanation could be found at Appendix):
























zTi L (η̃) zi
}











sj (η) | εi, ri
}
= 0, this expectation is justified under the assump-
tion that we could ignore the uncertainty of L (η̃). Then it will give us the inflated
estimation:





zTi L (η̂) zi
}−2
si (η̂) si (η̂)
T .
8
2. ri = 0: When the data point is missing, it’s even harder for us since there is no informa-
tion from data. We turn to use Taylor expansion to the score function.
For some η̄ between η and η̂,
si (η̂) = −α (1− ri)hi (η̂) zi
= −α (1− ri)
{
hi (η) + ḣi (η̄) z
T
i (η̂ − η)
}
zi
= −α (1− ri)
{
hi (η) + ḣi (η̄) z
T





1− α(1− ri)ḣi (η̄) zTi L (η̃) zi
}
which gives us:
si (η) si (η)
> ≈
{
1− (1− ri)αḣi (η̂) zTi L (η̂) zi
}−2
si (η̂) si (η̂)
T .
Putting this all together, we get the estimation for variance of score function:
n∑
i=1






si (η̂) si (η̂)
T
vi = 1− zTi L (η̂) zi
{ ri
σ2
+ (1− ri)αḣi (η̂)
}
,
meaning the variance-inflated estimator for V(η̂) is
















+ (1− ri)αḣi (η̂)
}
(6b)










which is equivalent to

















Notice that we need to assure thatH(η̂) to be negative definite in order for the estimation
procedure normally behaves.
After our experiments on simulations, we found that ḣi(η) can sometimes be negative,
which then may cause the Hessian matrix to be positive definite instead of negative definite.
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Thus, we instead take expectation of the variance estimator function with respect to missing
indices ri. This is effectively replace Hessian matrix with its expectation, which is always
positive. The inflated variance then become






si (η̂) si (η̂)
T
}
[E {H (η̂)}]−1 ,
ṽi = 1 + aiz
T













with the expectation of hessian being





















3.3 Comparison to Other Methods in Simulation
In Mass-Spectrometry(MS) metabolites data, missing values always exist due to multiple
reasons. Based on the properties of MS, many algorithms have been developed or adopted
to solve this problem. In this thesis, I thoroughly compared some selected methods to our
method, and the results will be displayed in each chapter, respectively. Let’s begin with
introduction of these methods.
3.3.1 Introduction to Imputation Methods
Imputation methods are a group of methods that are comprehensively well-developed
dedicated to different assumption with respect to different intuition and experiment condi-
tion. Their intention seems intuitive yet powerful. For general MS metabolomics data, I
selected five of the best-performed methods according to [2].
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1. min: Impute missing values with the minimum value among each metabolites across
samples.
This method comes from an intuition that the missing values exist due to the true
target metabolite concentration is too below to be detected in experiment. Then it is
reasonable to assume the lowest metabolites concentration is approximately equal to the
lowest threshold. It generally shows inflated type 1 error and low power for regression
analysis[5].
2. svd : SVD imputation obtains a set of mutually orthogonal expression patterns that can
be further linearly combined to approximate certain mechanism[6]. Later we will see
SVD also appears in dimension reduction. A simplified algorithm procedure should look
like below:
a. Replace all missing values with row(each metabolites) means.
b. Compute a rank-k(k is set to be the same as latent factors dimension) approximation
to the imputed matrix.
c. Replace values in the imputed positions with corresponding values from the approx-
imation computed in Step 2.
d. Repeat Steps 2 and 3 until convergence.
3. knn-var : k-Nearest Neighbors per metabolites.
KNN finds k-nearest neighborhoods for each term, and use the average value among
them to impute the missing value. When we choose to measure the distance between
metabolites, this method shows a low type 1 error rate, but large power. especially when
the amount of missing values are bigger. Thus, I finally turned to use knn-obs-sel in
simulations.
4. knn-obs-sel : KNN per observation(samples) using selected metabolites.
This method measures the distance between different samples, but using only selected
part of the variables as measurement. To me, it makes more sense intuitively since
samples are assumed to be independent in our model. Yet the metabolites are assumed
to be correlated in form of cluster. It also shows high power and an overall marginal
type 1 error rate, even for a high amount of missing values in [2].
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5. mice: Multiple Imputation(MI) by Chained Equations.
MI is specifically designed to improve the performance of stochastic imputation meth-
ods. Stochastic imputations normally use assumption that there exist an underlying
mean model for missing values. The stochastic part is introduced to simulate the ran-
domness when the data is generated. When applying MI, the first step is to impute the
incomplete data m times to produce m complete datasets. Then statistical analysis and
inference is performed on the m datasets, individually. Using tricks like averaging the
total coefficients estimation, MI imputation is finalized.
In practice, we found that MI requires much more computational resources than the
previous methods, which isn’t realistic in real-world metabolomics data analysis. Thus,
we didn’t include it in our final simulations.
3.3.2 Simulation Results
Before we start to do results analysis, it is worth mentioning that we are also comparing
our method to OLS, dSVA, and method directly from MetabMiss[4], which in practice is the
starting value of out current one. Detailed introduction of these methods won’t be covered
in this thesis since they are relatively trivial.
Noted that the basic simulation framework for this thesis is universal. We set Z to be
and all-one vector corresponding to nuisance parameters, X to be a half zero half one vector
corresponding to parameters of interest. For latent factors C,the dimension is set to be 10.
Data matrix is set to be a 1200(metabolites) by 600(samples) matrix, among which there
are around 20% are fully observed; 20% are missing less than 5%, which are considered as
missing at random(MAR); 25% are missing at 5%-50%, which are considered as missing not
at random(MNAR).
To begin with, we consider the confidence interval coverage for the effects of interest βg
for each method in Figure 2. It shows the fraction of effects of interest {βg}g∈M in all 50





stratified by the simulated ”true” |βg|. As you can see in Figure 2, our methods universally
keeps the CI coverage closest to 95%. Also, note that min performs relatively better than
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other imputation methods since this assumption are heavily dependent to real experiment
experience.
Figure 2: Confidence Interval(CI) Coverage
Figure 3, from top to bottom, from left to right, shows the false discovery propor-
tion(FDP) and true recovery proportion(TRP) for metabolites with q-values ≤ 0.05, 0.1,
0.15 and 0.2.
The TRP is the fraction of metabolites with non-zero βg identified at a given q-value
threshold. q-values were determined using the qvalue package in R (Storey et al., 2015).
13
Figure 3: False Discovery Rate and True Recovery Proportion
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4.0 Dimension Reduction Using Principal Component Regression
In this chapter, we will briefly introduce PCR, the commonly used dimension reduction
methods. Then it will be discussed how PCR is used to help us do dimension reduction of
metabolomics data. Finally I will compare our method to other algorithms mentioned in
precious chapter.
4.1 Introduction to PCR
Figure 4: Principle Component Analysis from Hastie, Tibshirani and Friedman
Principal component regression (PCR) is a regression analysis technique that is based on
principal component analysis (PCA), which is basically a projection computing algorithms
that could be used to change basis on the coefficients of interest. More specifically, PCR is
used for a high dimensional standard linear regression model. This technique could be used to
explore data analysis and prediction. The plot above shows how PCA reduce the dimension
where its variance is biggest when the dimension is relatively small. For linear regression
model, PCR is fundamentally selecting the coefficients that can explain the variance mostly.
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For a general PCA problem, we demonstrate it to be an optimization problem, where we
need to first write out the general mean model:
f(λ) = µ+ Vqλ
where µ is the location parameter, Vq here is the orthogonal basis that represent the hyper-
plane that can mostly explain variance and λ is a q-vector of parameters. They combined
to create an hyperplane of rank-q,which is the dimension reduced representation of original
data matrix. The objective function should be built such that the least squares amounts is
minimized in terms of the reconstruction error[3]:





By trivial mathematical derivation, the solution is analytically expressed as follow:
1. First construct a singular value decomposition to X = UDVT .
2. Then the first K columns of UD are the K principal components of X.
4.2 Factor Analysis Using PCR
In the remainder of this chapter, we will rewrite our mean model so that it will be easier
to interpret.
Y = ΓZT +LCT +E (8)
where Z ∈ Rn×r are observed nuisance covariates (like the intercept), which we assume
ZTC = 0 for identification purposes (i.e. C is orthogonal to Z). For the residuals, we will
also assume
E ∼MNp×n(0,Σ, In),
where Σ = (σgh)g∈[p];h∈[p] is a sparse matrix.
The goal is to do factor analysis for L ∈ Rp×K . Based on the classical PCA algorithms,
we adopt it to our models as follow:
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1. Use MetabMiss[4] to estimate αg, δg for missingness mechanism, as well as C,L, σgg, for
all g ∈ [p]. Let Ĉ, L̂ be the estimate for C,L, respectively.
2. Use our new method to update estimation of coefficients of interest L, which we do by
regressing Yg· onto [Z, Ĉ] for each g with missing proportion less than 50%.





















Since from our assumed mean model, we can only identify the expectation of the mul-
tiplication LC>, in which case we couldn’t identify each one up to rotation. Thus for
identification purpose, we need to define a transformed C̃ such that
1
(n− r)
C̃>P⊥Z C̃ = IK .




4. To guarantee E(Y | Z) = L̃C̃> = L̂Ĉ>, we also let L̃ = L̂R̂.










. . . 0
0 0 λ̂K
 Û>.
where Û ∈ RK×K be a unitary matrix
6. The PCA estimates for the C and L then, are Ĉ(PCA) = ĈR̂−1Û and L̂(PCA) = L̂R̂Û .
It can be easily checked that both of these estimates have orthogonal columns.
17
Figure 5: Principle Component Regression
4.3 Simulations
In this section, we demonstrate the result by showing the absolute difference between the
PCR of simulation and PCA of other estimation methods. As for the simulation parameters,
they are basically the same as the setup in chapter 3, except that we assume there are no
other coefficients other than intercept and latent factors.
The first two plots in Figure 5 is about the absolute difference between estimating meth-
ods and the simulated parameters of first and last column of the PCR result. It clearly
shows that our methods is doing the best job finding principle component even from the
latent factors. For the last two plots, they compare row sum of square of L̂PCA by absolute
difference,. This term gives us a proportion variance explained by C, which is identifiable.
The last plot is the same as the third one with only the first three terms, which gives us a
better point of view of our model’s performance.
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5.0 Estimation of Correlation between Metabolites
In this chapter, we will introduce how do we get the estimation for correlation coeffi-
cients between metabolites. Also, based on the estimator procedure, we can easily get the
estimation of correlation covariance.
5.1 Correlation Estimator and Covariance
Similar as chapter 3,for the metabolites correlations, we could easily write the likelihood
functions based on our previous analysis. For each pair of metabolites, there are total n
pairs of samples, which could be further divided into three different kinds. Then we could
write this problem as an optimization problem with form






c11i (ρgh) if ygi and yhi are both observed
c10i (ρgh) if one of both observed.
c00i (ρgh) if non of both are observed.
Based on the three different kinds of sample pairs, we established three different likelihood
using Bayesian methodology that is given below.
If both metabolites are observed
c11i = logP (ρgh | rgi = rhi = 1, ygi, yhi)
= logP (rgi = rhi = 1 | ygi, yhi)N (ygi, yhi)
∝ logN (ygi, yhi)
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If only one metabolite of both is observed
c10i = logP (ρgh | rgi = 1, rhi = 0, ygi)
= logP (rgi = 1, rhi = 0 | ygi)P (ygi)
= log
∫
P (rgi = 1, rhi = 0 | yhi, ygi)P (yhi | ygi) dyhi
∝ log
∫
(1−Ψ{αh(yhi − δh)})N (yhi | ygi) dyhi
If both metabolites are missing
c00i = logP (ρgh | rgi = rhi = 0)
= log
∫∫
P (rgi = 0 | ygi)P (rhi = 0 | yhi)P (ygi, yhi) dygidyhi
= log
∫∫
(1−Ψ{αg(ygi − δg)}) (1−Ψ{αh(yhi − δh)})N (ygi, yhi) dygidyhi
By solving this optimization problem numerically, then could get our estimation for cor-
relation matrix. Detailed derivation that is used in software package will be supplied in
Appendix.










where ċi denote the derivation of each likelihood function above, respectively.
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Figure 6: Correlation Estimation
5.2 Simulation
In this chapter’s simulation, it’s worth mentioning that we simulate our covariance ma-
trix as a block-diagonal matrix, which means metabolites are correlated within clusters but
uncorrelated outside of clusters.
From left to right, Figure 6 compares each estimations in absolute difference, where true
correlation being zero and non-zero, respectively. Note that when the true values are zero,
all methods performs similar, among which SVD imputation performs slightly better than
the others. It makes sense because SVD is heavily relying on the assumption that the true
correlation is equal to zero. But when the true value is non-zero, difference between methods
starts to show, and SVD is doing much worse.
21
6.0 Conclusion
In this thesis, I studied the metabolomics data with non-ignorable missing data. Condi-
tional on the missingness mechanism and latent factor estimation methods from MetabMiss
[4], it is possible for us to utilize the normality assumption buried in metabolomics data and
get a much powerful estimation.
I evaluated our estimation in three different chapters where each one focus on one point.
By using the normality assumption, we are able to build maximal likelihood estimation model
for metabolomics data. We showed that overall my method has a consistent and accurate
estimate for the confident intervals. Also, we showed it has a much better performance in
terms to false discovery rate control and power.
Then I showed how I am able to do dimension reduction with missing not at random
data. It showed that based on our estimation method, PCA gives us a decreasing proportion
estimation of variance with orthogonal regression parameters.
For the last parts, I showed the estimation of correlation between different metabolites
and how my methods achieved a better performs especially when the true correlation coef-
ficients are zero.
In my thesis, we thoroughly investigated the estimation and inference methods in biolog-
ical data with missing not at random values. Future work are expected to include seeking a
more fundamental proof of our normality assumption. Besides that, we may seek to develop a
more powerful way to account for the missing mechanism with this normality assumptions.
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Appendix A Inflated Variance Estimator
























zTi L (η̃) zi
}











sj (η) | εi, ri
}
= 0, this expectation is justified under the assumption
that we could ignore the uncertainty of L (η̃). Then it will give us the inflated estimation:





zTi L (η̂) zi
}−2
si (η̂) si (η̂)
T .
ri = 0: When the data point is missing, it’s even harder for us since there is no informa-
tion from data. We turn to use Taylor expansion to the score function.
       For some η̄ between η and η̂,
si (η̂) = −α (1− ri)hi (η̂) zi
= −α (1− ri)
{
hi (η) + ḣi (η̄) z
T
i (η̂ − η)
}
zi
= −α (1− ri)
{
hi (η) + ḣi (η̄) z
T





1− α(1− ri)ḣi (η̄) zTi L (η̃) zi
}
which gives us:
si (η) si (η)
> ≈
{
1− (1− ri)αḣi (η̂) zTi L (η̂) zi
}−2
si (η̂) si (η̂)
T .
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Appendix B Basic Derivation of Mean Model
Let Y ∈ Rp×n be the #metabolite by #sample data matrix. Some of the entries of Y
are missing not at random (MNAR).
Y = LC> +E, C ∈ Rn×K , L ∈ Rp×K




For residuals E, we have the following properties:
E(E) = 0n×K
V(Eg·) = σ2gIn V(Eg·,Eh·) = σghIn
V(E·i) = Σp×p V(E·i,E·j) = 0p×p
We could rewrite the equation as:
yg· = CLg· +Eg·
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V(y·i) = V(LCi·) + V(E·i)
= LV(Ci·)L> + Σ
= LΩL> + Σ
V(yg·) = V(CLg·) + V(Eg·)
= V(C>i·Lg·)In + V(Eg·)
= L>g·ΩLg·In + σ
2
gIn
V(yg·,yh·) = V(CLg· +Eg·,CLh· +Eh·)
= V(CLg·,CLh·) + V(Eg·,Eh·) + V(CLg·,Eh·) + V(CLh·,Eg·)
= L>g·ΩLh·In + 0 + 0 + 0
= L>g·ΩLh·In
V(y·i,y·j) = V(LCi· +E·i,LCj· +E·j)




Appendix C Derivation of Likelihood Functions of Correlation Estimation
C.1 Estimating the Correlation between Metabolites
If both metabolites are fully observed or at least with less than 0.05 missing values
logPrgi=rhi=1,ygi,yhi(ρgh) = logP (rgi = rhi = 1 | ygi, yhi)φ(ygi, yhi)
∝ log dMV N(ygi, yhi)
Let
z ≡ (ygi − µg)
2
σ2g





Differentiating the function with respect to ρgh
∇ logP (ρgh)




















































If only one metabolite are fully observed or with less than 0.05 missing values
logPrgi=1,rhi=0,ygi(ρgh) = logP (rgi = 1, rhi = 0 | ygi)P (ygi)
= log
∫
P (rgi = 1, rhi = 0, yhi | ygi) dyhi
= log
∫
P (rgi = 1, rhi = 0 | yhi, ygi)P (yhi | ygi) dyhi
∝ log
∫
P (rhi = 0 | yhi)P (yhi | ygi) dyhi
∝ log
{∫













1− ρ2ghε+ µhi +
σh
σg
ρgh(ygi − µgi)− δh)













































P (rgi = 0 | ygi)P (rhi = 0 | yhi)P (ygi, yhi) dygidyhi
= log
∫∫
(1−Ψ{αg(ygi − δg)}) (1−Ψ{αh(yhi − δh)}) dMV N(ygi, yhi) dygidyhi
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(1−Ψ{αg(ygi − δg)}) (1−Ψ{αh(yhi − δh)}) dMV N(ygi, yhi) dygidyhi∫∫
(1−Ψ{αg(ygi − δg)}) (1−Ψ{αh(yhi − δh)}) dMV N(ygi, yhi) dygidyhi
∝
∫∫
(1−Ψ{αg(ygi − δg)}) (1−Ψ{αh(yhi − δh)}) dMV N(ygi, yhi)g(ρ) dygidyhi∫∫
(1−Ψ{αg(ygi − δg)}) (1−Ψ{αh(yhi − δh)}) dMV N(ygi, yhi) dygidyhi
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